Avastin: Reaction is sharp to FDA's steps to revoke approval as breast cancer treatment - latimes.com

Links shared publicly online about this topic.

  • 647
    total visits

Avastin: Reaction is sharp to FDA's steps to revoke approval as breast cancer treatment - latimes.com

latimes.com

The Food and Drug Administration took steps Thursday to withdraw its approval for use of Avastin as a breast cancer drug after citing clinical trials that failed to show that Avastin prolonged life among breast cancer patients. The decision drew sharp and quick reactions.

View full resource at latimes.com

Tags: Cancer, Breast Cancer, Colorectal Cancer Medication, Drug, Women's Health, FDA, Avastin

  • Share

Most Recently Shared on December 18, 2010 at 3:58 am By:

LATimeshealth LA Times Health News

Avastin: Reaction is sharp to FDA's steps to revoke approval as breast cancer treatment http://lat.ms/en0muf

1 year ago...

Advertisement